Global Neurovascular Embolization Coils Market Growth 2026-2032
The global Neurovascular Embolization Coils market size is predicted to grow from US$ 1035 million in 2025 to US$ 1537 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.
Neurovascular Embolization Coils are implantable neurointerventional devices delivered through a microcatheter into intracranial or other neurovascular lesions to mechanically fill the target space, promote local thrombus formation, and reduce or permanently occlude abnormal blood flow. The implant is generally constructed from radiopaque platinum or platinum-based alloys and engineered into complex three-dimensional, helical, or other secondary shapes, with different coil diameters, lengths, softness levels, and packing characteristics designed for framing, filling, and finishing during embolization. Mainstream systems use controllable mechanical or electrolytic detachment, while selected products incorporate hydrogel, polymer fibers, or other enhancement technologies to improve volumetric filling, conformability, or thrombogenic performance. The market primarily covers sterile single-use detachable neurovascular embolization coil systems used in endovascular treatment of intracranial aneurysms, with additional applications in cerebral arteriovenous malformations, arteriovenous fistulae, and other approved neurovascular abnormalities. Product differentiation is driven by coil geometry, softness, detachment reliability, packing efficiency, microcatheter compatibility, radiopacity, and the ability to provide predictable deployment in anatomically complex lesions.
Product differentiation increasingly centers on complex geometry, softness, packing efficiency, and controllable detachment
Detachable coils dominate commercial neurovascular coiling, with mechanical and electrolytic detachment technologies coexisting
North America remains a leading high-value market, while Asia Pacific is gaining strategic importance
Competition combines established multinational neurovascular platforms with an expanding group of Chinese manufacturers
The midstream value pool is concentrated in proprietary coil design, manufacturing know-how, detachment technology, quality systems, regulatory registrations, clinical evidence, and physician-facing commercial capabilities. Downstream demand is generated primarily by tertiary hospitals, comprehensive stroke centers, academic medical centers, and other hospitals with established neurointerventional capabilities. A significant share of value is therefore created outside raw materials themselves: intellectual property, validated manufacturing processes, regulatory compliance, clinical education, procedural support, and hospital access account for a substantial portion of the economic value of the final product. Direct sales are important in large developed markets and major hospital accounts, while distributors remain significant in smaller and geographically fragmented markets.
By technology, bare-metal platinum and platinum-alloy detachable coils continue to form the core market, while polymer- or hydrogel-enhanced products represent a differentiated segment focused on higher volumetric filling or modified thrombogenic characteristics. Mechanical and electrolytic detachment technologies both maintain established commercial positions, making reliability, deployment speed, repositionability, and compatibility with existing hospital workflows important purchasing considerations. Size architecture is another major source of differentiation: broad portfolios spanning small-diameter finishing coils through longer and higher-volume framing or filling coils allow suppliers to cover a greater proportion of procedural requirements and strengthen their position within hospital accounts.
Asia Pacific is becoming increasingly important to the competitive structure of the market. Japan maintains an established neurointerventional market and domestic manufacturing base, while China combines rapid development of neurointerventional centers with growing penetration of locally manufactured coil systems. In China, centralized procurement and hospital cost control place pressure on unit pricing, but expanding product availability, increased procedural accessibility, and accelerated domestic substitution support unit demand. Chinese manufacturers are also extending regulatory registrations beyond their domestic market, increasing competitive interaction with multinational suppliers in selected emerging and developed markets. Other Asian markets remain more dependent on imported products and distributor networks, creating opportunities for suppliers with broad regulatory coverage and efficient regional channels.
This Insight Report provides a comprehensive analysis of the global Neurovascular Embolization Coils landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurovascular Embolization Coils portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Embolization Coils market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Embolization Coils and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Embolization Coils.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Embolization Coils market by product type, application, key manufacturers and key regions and countries.
Neurovascular Embolization Coils are implantable neurointerventional devices delivered through a microcatheter into intracranial or other neurovascular lesions to mechanically fill the target space, promote local thrombus formation, and reduce or permanently occlude abnormal blood flow. The implant is generally constructed from radiopaque platinum or platinum-based alloys and engineered into complex three-dimensional, helical, or other secondary shapes, with different coil diameters, lengths, softness levels, and packing characteristics designed for framing, filling, and finishing during embolization. Mainstream systems use controllable mechanical or electrolytic detachment, while selected products incorporate hydrogel, polymer fibers, or other enhancement technologies to improve volumetric filling, conformability, or thrombogenic performance. The market primarily covers sterile single-use detachable neurovascular embolization coil systems used in endovascular treatment of intracranial aneurysms, with additional applications in cerebral arteriovenous malformations, arteriovenous fistulae, and other approved neurovascular abnormalities. Product differentiation is driven by coil geometry, softness, detachment reliability, packing efficiency, microcatheter compatibility, radiopacity, and the ability to provide predictable deployment in anatomically complex lesions.
Key Findings
Intracranial aneurysm embolization remains the principal clinical demand for Neurovascular Embolization CoilsProduct differentiation increasingly centers on complex geometry, softness, packing efficiency, and controllable detachment
Detachable coils dominate commercial neurovascular coiling, with mechanical and electrolytic detachment technologies coexisting
North America remains a leading high-value market, while Asia Pacific is gaining strategic importance
Competition combines established multinational neurovascular platforms with an expanding group of Chinese manufacturers
Market Trends
Neurovascular Embolization Coils are evolving from relatively standardized platinum implants toward highly differentiated coil platforms optimized for specific stages of aneurysm embolization. Manufacturers are expanding complex three-dimensional framing designs, ultra-soft filling and finishing coils, longer and higher-volume configurations, and low-profile products compatible with smaller microcatheters. Product development increasingly emphasizes predictable wall apposition, reduced catheter kickback, improved packing density, controlled deployment, and rapid, reliable detachment. Bare-metal platinum and platinum-alloy coils remain the foundation of the market, while hydrogel, polymer-fiber, and other enhanced coil technologies provide additional differentiation in selected clinical settings. Another important direction is portfolio integration: major neurovascular companies increasingly position coils together with microcatheters, coil-assist stents, balloons, access devices, and other aneurysm treatment technologies, strengthening procedural compatibility and hospital-level account penetration rather than competing solely on the individual coil.Market Dynamics
Drivers
Demand is supported by the continuing clinical burden of intracranial aneurysms, broader availability of neurovascular imaging, increasing detection of previously undiagnosed aneurysms, and expansion of specialized neurointerventional treatment capacity. Endovascular coiling remains an established minimally invasive treatment pathway for many ruptured and unruptured aneurysms and retains particular clinical value where preservation of the parent artery and immediate intrasaccular occlusion are required. Increasing numbers of trained neurointerventional specialists, expansion of comprehensive stroke centers, wider adoption of advanced microcatheter systems, and growing access to neurointervention in emerging healthcare markets are supporting procedure volumes. Continuous improvements in coil softness, shape stability, packing efficiency, and detachment reliability also expand physician choice and facilitate treatment of smaller, irregular, and technically challenging aneurysms.Restraints
The market faces significant pricing and reimbursement pressure because intracranial aneurysm embolization commonly requires multiple coils in a single procedure, making implant expenditure highly visible to hospitals and payers. Centralized procurement, tendering, reimbursement controls, and hospital cost-management programs can therefore reduce average selling prices even when procedural volumes rise. Treatment remains highly operator dependent and requires sophisticated imaging, experienced neurointerventional teams, and specialized procedural infrastructure, limiting adoption in healthcare systems with insufficient neurovascular capacity. In addition, flow-diverting stents and intrasaccular flow-disruption devices have expanded the treatment options available for selected aneurysm anatomies, particularly complex and wide-neck lesions, creating substitution pressure on conventional coil-only procedures in some clinical segments.Opportunities
The strongest structural opportunities lie in broader neurointerventional penetration in Asia Pacific and other underserved markets, continued localization of manufacturing, and expansion of differentiated coil portfolios across multiple price and performance tiers. Products that combine low radial force with stable framing, higher volumetric filling, smaller delivery profiles, and predictable detachment can address unmet needs in small, irregular, distal, and difficult-to-pack aneurysms. Hydrogel-enhanced, fiber-enhanced, and other advanced coil technologies also provide opportunities to improve packing characteristics and support premium positioning where clinical evidence justifies differentiated performance. For Chinese manufacturers, expansion from domestic commercialization into regulated overseas markets represents an additional growth pathway, while multinational companies can benefit from broader hospital access, integrated aneurysm treatment portfolios, and region-specific product configurations.Challenges
Neurovascular Embolization Coils require extremely consistent performance because deployment takes place within fragile intracranial vessels and aneurysm sacs where device deformation, premature detachment, migration, excessive radial force, or delivery resistance can result in serious clinical consequences. Manufacturers therefore face stringent requirements for raw-material consistency, microcoil forming, joint integrity, detachment reliability, fatigue performance, sterility, packaging, traceability, and post-market surveillance. Commercial success also depends on obtaining regulatory approvals across multiple jurisdictions while maintaining extensive physician training and clinical support. At the same time, intensifying competition among global platforms and emerging domestic manufacturers is increasing pressure on pricing and product refresh cycles, while the growing use of alternative aneurysm technologies requires coil manufacturers to demonstrate continued clinical relevance rather than relying solely on established procedure volumes.Industry Chain Analysis
The upstream supply chain for Neurovascular Embolization Coils is concentrated in high-specification medical-grade materials and precision components. Key inputs include platinum and platinum-based alloy wire, tungsten-containing radiopaque alloys, stainless steel or other delivery-wire materials, polymer fibers, hydrogel or specialty polymer materials, micro-scale joining and detachment components, medical-grade packaging, and sterilization services. Material purity, wire dimensional control, mechanical properties, radiopacity, biocompatibility, and lot-to-lot consistency directly influence implant performance. Manufacturing requires precision wire processing, primary and secondary coil forming, shape setting, micro-welding or joining, detachment-interface assembly, surface treatment, cleanroom assembly, inspection, packaging, sterilization, and extensive mechanical and functional validation. These processes create meaningful technical barriers despite the relatively small physical size of the final implant.The midstream value pool is concentrated in proprietary coil design, manufacturing know-how, detachment technology, quality systems, regulatory registrations, clinical evidence, and physician-facing commercial capabilities. Downstream demand is generated primarily by tertiary hospitals, comprehensive stroke centers, academic medical centers, and other hospitals with established neurointerventional capabilities. A significant share of value is therefore created outside raw materials themselves: intellectual property, validated manufacturing processes, regulatory compliance, clinical education, procedural support, and hospital access account for a substantial portion of the economic value of the final product. Direct sales are important in large developed markets and major hospital accounts, while distributors remain significant in smaller and geographically fragmented markets.
Segment Insights
By coil shape, complex three-dimensional coils represent the central commercial category because their spatial configurations are designed to establish a stable framework, improve aneurysm-wall apposition, and support subsequent filling, while helical coils remain an important complementary option for versatile filling and finishing. By embolization role, product portfolios are increasingly structured around framing, filling, and finishing functions, although certain coil families are designed for use across multiple stages. Softness has also become a major competitive variable, with standard or structurally supportive coils used where framing stability is required and progressively softer coils used to occupy residual spaces while reducing force against the aneurysm wall.By technology, bare-metal platinum and platinum-alloy detachable coils continue to form the core market, while polymer- or hydrogel-enhanced products represent a differentiated segment focused on higher volumetric filling or modified thrombogenic characteristics. Mechanical and electrolytic detachment technologies both maintain established commercial positions, making reliability, deployment speed, repositionability, and compatibility with existing hospital workflows important purchasing considerations. Size architecture is another major source of differentiation: broad portfolios spanning small-diameter finishing coils through longer and higher-volume framing or filling coils allow suppliers to cover a greater proportion of procedural requirements and strengthen their position within hospital accounts.
Downstream Market Opportunities
Intracranial aneurysm treatment accounts for the dominant downstream opportunity, covering both ruptured and unruptured aneurysms treated through endovascular coil embolization. The opportunity is increasingly differentiated by aneurysm anatomy rather than simply by procedure count. Small and irregular aneurysms create demand for ultra-soft, low-profile coils; larger aneurysms require efficient volumetric filling; and wide-neck or complex aneurysms frequently require coils to operate as part of a broader treatment strategy involving adjunctive stents or balloons. Cerebral arteriovenous malformations, arteriovenous fistulae, and other approved neurovascular embolization indications provide additional demand. Expansion of neurointerventional services into secondary regional centers and emerging healthcare systems creates further opportunity as diagnosis, referral pathways, and physician training improve.Regional Insights
North America remains one of the most important high-value markets for Neurovascular Embolization Coils, supported by a mature neurointerventional infrastructure, broad access to advanced aneurysm treatment technologies, established reimbursement pathways, and extensive participation by leading multinational manufacturers. Europe also represents a mature market with sophisticated clinical practice, although procurement structures and country-level reimbursement conditions create greater pricing heterogeneity. Both regions increasingly use coils as part of multi-technology aneurysm treatment portfolios, with clinical selection influenced by lesion anatomy, physician preference, and availability of adjunctive or alternative devices.Asia Pacific is becoming increasingly important to the competitive structure of the market. Japan maintains an established neurointerventional market and domestic manufacturing base, while China combines rapid development of neurointerventional centers with growing penetration of locally manufactured coil systems. In China, centralized procurement and hospital cost control place pressure on unit pricing, but expanding product availability, increased procedural accessibility, and accelerated domestic substitution support unit demand. Chinese manufacturers are also extending regulatory registrations beyond their domestic market, increasing competitive interaction with multinational suppliers in selected emerging and developed markets. Other Asian markets remain more dependent on imported products and distributor networks, creating opportunities for suppliers with broad regulatory coverage and efficient regional channels.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Neurovascular Embolization Coils Industry Forecast” looks at past sales and reviews total world Neurovascular Embolization Coils sales in 2025, providing a comprehensive analysis by region and market sector of projected Neurovascular Embolization Coils sales for 2026 through 2032. With Neurovascular Embolization Coils sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Embolization Coils industry.This Insight Report provides a comprehensive analysis of the global Neurovascular Embolization Coils landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurovascular Embolization Coils portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Embolization Coils market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Embolization Coils and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Embolization Coils.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Embolization Coils market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Complex Coils
- Helical Coils
Segmentation by Embolization Role:
- Framing Coils
- Filling Coils
- Finishing Coils
- Universal Coils
Segmentation by Coil Softness:
- Standard Coils
- Soft Coils
- Extra Soft and Super Soft Coils
Segmentation by Detachment Mechanism:
- Mechanical Detachment Coils
- Electrolytic Detachment Coils
- Others
Segmentation by Application:
- Intracranial Aneurysm Embolization
- Cerebral Arteriovenous Malformation Embolization
- Other Neurovascular Abnormality Embolization
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Stryker Corporation
- Medtronic plc
- Johnson & Johnson
- Terumo Corporation
- Penumbra, Inc.
- Balt Group
- Kaneka Corporation
- Genesis MedTech Group
- MicroPort NeuroScientific Corporation
- Wallaby Medical Holding, Inc.
- Shanghai HeartCare Medical Technology Corporation Limited
- Peijia Medical Limited
- Zylox-Tonbridge Medical Technology Co., Ltd.
- Beijing Taijieweiye Technology Co., Ltd.
- Shunmei Medical Co., LTD
- Hunan Ruikangtong Technology Development Co., Ltd.
- Shandong Visee Medical Devices Co., Ltd.
- Conlife Medical Scientific (Shenzhen) Co., Ltd.
- Zhuhai NeuroSafe Medical Co., Ltd.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Neurovascular Embolization Coils market?
- What factors are driving Neurovascular Embolization Coils market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Neurovascular Embolization Coils market opportunities vary by end market size?
- How does Neurovascular Embolization Coils break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Embolization Coils Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neurovascular Embolization Coils by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neurovascular Embolization Coils by Country/Region, 2021, 2025 & 2032
2.2 Neurovascular Embolization Coils Segment by Type
2.2.1 Complex Coils
2.2.2 Helical Coils
2.2.3 Neurovascular Embolization Coils Sales by Type
2.2.3.1 Global Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
2.2.3.2 Global Neurovascular Embolization Coils Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Neurovascular Embolization Coils Sale Price by Type (2021-2026)
2.3 Neurovascular Embolization Coils Segment by Embolization Role
2.3.1 Framing Coils
2.3.2 Filling Coils
2.3.3 Finishing Coils
2.3.4 Universal Coils
2.3.5 Neurovascular Embolization Coils Sales by Embolization Role
2.3.5.1 Global Neurovascular Embolization Coils Sales Market Share by Embolization Role (2021-2026)
2.3.5.2 Global Neurovascular Embolization Coils Revenue and Market Share by Embolization Role (2021-2026)
2.3.5.3 Global Neurovascular Embolization Coils Sale Price by Embolization Role (2021-2026)
2.4 Neurovascular Embolization Coils Segment by Coil Softness
2.4.1 Standard Coils
2.4.2 Soft Coils
2.4.3 Extra Soft and Super Soft Coils
2.4.4 Neurovascular Embolization Coils Sales by Coil Softness
2.4.4.1 Global Neurovascular Embolization Coils Sales Market Share by Coil Softness (2021-2026)
2.4.4.2 Global Neurovascular Embolization Coils Revenue and Market Share by Coil Softness (2021-2026)
2.4.4.3 Global Neurovascular Embolization Coils Sale Price by Coil Softness (2021-2026)
2.5 Neurovascular Embolization Coils Segment by Detachment Mechanism
2.5.1 Mechanical Detachment Coils
2.5.2 Electrolytic Detachment Coils
2.5.3 Others
2.5.4 Neurovascular Embolization Coils Sales by Detachment Mechanism
2.5.4.1 Global Neurovascular Embolization Coils Sales Market Share by Detachment Mechanism (2021-2026)
2.5.4.2 Global Neurovascular Embolization Coils Revenue and Market Share by Detachment Mechanism (2021-2026)
2.5.4.3 Global Neurovascular Embolization Coils Sale Price by Detachment Mechanism (2021-2026)
2.6 Neurovascular Embolization Coils Segment by Application
2.6.1 Intracranial Aneurysm Embolization
2.6.2 Cerebral Arteriovenous Malformation Embolization
2.6.3 Other Neurovascular Abnormality Embolization
2.6.4 Neurovascular Embolization Coils Sales by Application
2.6.4.1 Global Neurovascular Embolization Coils Sale Market Share by Application (2021-2026)
2.6.4.2 Global Neurovascular Embolization Coils Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Neurovascular Embolization Coils Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neurovascular Embolization Coils Breakdown Data by Company
3.1.1 Global Neurovascular Embolization Coils Annual Sales by Company (2021-2026)
3.1.2 Global Neurovascular Embolization Coils Sales Market Share by Company (2021-2026)
3.2 Global Neurovascular Embolization Coils Annual Revenue by Company (2021-2026)
3.2.1 Global Neurovascular Embolization Coils Revenue by Company (2021-2026)
3.2.2 Global Neurovascular Embolization Coils Revenue Market Share by Company (2021-2026)
3.3 Global Neurovascular Embolization Coils Sale Price by Company
3.4 Key Manufacturers Neurovascular Embolization Coils Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Embolization Coils Product Location Distribution
3.4.2 Players Neurovascular Embolization Coils Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR EMBOLIZATION COILS BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Embolization Coils Market Size by Geographic Region (2021-2026)
4.1.1 Global Neurovascular Embolization Coils Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neurovascular Embolization Coils Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neurovascular Embolization Coils Market Size by Country/Region (2021-2026)
4.2.1 Global Neurovascular Embolization Coils Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neurovascular Embolization Coils Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurovascular Embolization Coils Sales Growth
4.4 APAC Neurovascular Embolization Coils Sales Growth
4.5 Europe Neurovascular Embolization Coils Sales Growth
4.6 Middle East & Africa Neurovascular Embolization Coils Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Embolization Coils Sales by Country
5.1.1 Americas Neurovascular Embolization Coils Sales by Country (2021-2026)
5.1.2 Americas Neurovascular Embolization Coils Revenue by Country (2021-2026)
5.2 Americas Neurovascular Embolization Coils Sales by Type (2021-2026)
5.3 Americas Neurovascular Embolization Coils Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Embolization Coils Sales by Region
6.1.1 APAC Neurovascular Embolization Coils Sales by Region (2021-2026)
6.1.2 APAC Neurovascular Embolization Coils Revenue by Region (2021-2026)
6.2 APAC Neurovascular Embolization Coils Sales by Type (2021-2026)
6.3 APAC Neurovascular Embolization Coils Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Embolization Coils by Country
7.1.1 Europe Neurovascular Embolization Coils Sales by Country (2021-2026)
7.1.2 Europe Neurovascular Embolization Coils Revenue by Country (2021-2026)
7.2 Europe Neurovascular Embolization Coils Sales by Type (2021-2026)
7.3 Europe Neurovascular Embolization Coils Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Embolization Coils by Country
8.1.1 Middle East & Africa Neurovascular Embolization Coils Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neurovascular Embolization Coils Revenue by Country (2021-2026)
8.2 Middle East & Africa Neurovascular Embolization Coils Sales by Type (2021-2026)
8.3 Middle East & Africa Neurovascular Embolization Coils Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Embolization Coils
10.3 Manufacturing Process Analysis of Neurovascular Embolization Coils
10.4 Industry Chain Structure of Neurovascular Embolization Coils
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Embolization Coils Distributors
11.3 Neurovascular Embolization Coils Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR EMBOLIZATION COILS BY GEOGRAPHIC REGION
12.1 Global Neurovascular Embolization Coils Market Size Forecast by Region
12.1.1 Global Neurovascular Embolization Coils Forecast by Region (2027-2032)
12.1.2 Global Neurovascular Embolization Coils Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neurovascular Embolization Coils Forecast by Type (2027-2032)
12.7 Global Neurovascular Embolization Coils Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.1.3 Stryker Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Medtronic plc
13.2.1 Medtronic plc Company Information
13.2.2 Medtronic plc Neurovascular Embolization Coils Product Portfolios and Specifications
13.2.3 Medtronic plc Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic plc Main Business Overview
13.2.5 Medtronic plc Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Neurovascular Embolization Coils Product Portfolios and Specifications
13.3.3 Johnson & Johnson Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Terumo Corporation
13.4.1 Terumo Corporation Company Information
13.4.2 Terumo Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.4.3 Terumo Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Terumo Corporation Main Business Overview
13.4.5 Terumo Corporation Latest Developments
13.5 Penumbra, Inc.
13.5.1 Penumbra, Inc. Company Information
13.5.2 Penumbra, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
13.5.3 Penumbra, Inc. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Penumbra, Inc. Main Business Overview
13.5.5 Penumbra, Inc. Latest Developments
13.6 Balt Group
13.6.1 Balt Group Company Information
13.6.2 Balt Group Neurovascular Embolization Coils Product Portfolios and Specifications
13.6.3 Balt Group Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Balt Group Main Business Overview
13.6.5 Balt Group Latest Developments
13.7 Kaneka Corporation
13.7.1 Kaneka Corporation Company Information
13.7.2 Kaneka Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.7.3 Kaneka Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kaneka Corporation Main Business Overview
13.7.5 Kaneka Corporation Latest Developments
13.8 Genesis MedTech Group
13.8.1 Genesis MedTech Group Company Information
13.8.2 Genesis MedTech Group Neurovascular Embolization Coils Product Portfolios and Specifications
13.8.3 Genesis MedTech Group Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Genesis MedTech Group Main Business Overview
13.8.5 Genesis MedTech Group Latest Developments
13.9 MicroPort NeuroScientific Corporation
13.9.1 MicroPort NeuroScientific Corporation Company Information
13.9.2 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.9.3 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MicroPort NeuroScientific Corporation Main Business Overview
13.9.5 MicroPort NeuroScientific Corporation Latest Developments
13.10 Wallaby Medical Holding, Inc.
13.10.1 Wallaby Medical Holding, Inc. Company Information
13.10.2 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
13.10.3 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wallaby Medical Holding, Inc. Main Business Overview
13.10.5 Wallaby Medical Holding, Inc. Latest Developments
13.11 Shanghai HeartCare Medical Technology Corporation Limited
13.11.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
13.11.2 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Product Portfolios and Specifications
13.11.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
13.11.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
13.12 Peijia Medical Limited
13.12.1 Peijia Medical Limited Company Information
13.12.2 Peijia Medical Limited Neurovascular Embolization Coils Product Portfolios and Specifications
13.12.3 Peijia Medical Limited Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Peijia Medical Limited Main Business Overview
13.12.5 Peijia Medical Limited Latest Developments
13.13 Zylox-Tonbridge Medical Technology Co., Ltd.
13.13.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
13.13.2 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.13.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
13.13.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
13.14 Beijing Taijieweiye Technology Co., Ltd.
13.14.1 Beijing Taijieweiye Technology Co., Ltd. Company Information
13.14.2 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.14.3 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Beijing Taijieweiye Technology Co., Ltd. Main Business Overview
13.14.5 Beijing Taijieweiye Technology Co., Ltd. Latest Developments
13.15 Shunmei Medical Co., LTD
13.15.1 Shunmei Medical Co., LTD Company Information
13.15.2 Shunmei Medical Co., LTD Neurovascular Embolization Coils Product Portfolios and Specifications
13.15.3 Shunmei Medical Co., LTD Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shunmei Medical Co., LTD Main Business Overview
13.15.5 Shunmei Medical Co., LTD Latest Developments
13.16 Hunan Ruikangtong Technology Development Co., Ltd.
13.16.1 Hunan Ruikangtong Technology Development Co., Ltd. Company Information
13.16.2 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.16.3 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Hunan Ruikangtong Technology Development Co., Ltd. Main Business Overview
13.16.5 Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
13.17 Shandong Visee Medical Devices Co., Ltd.
13.17.1 Shandong Visee Medical Devices Co., Ltd. Company Information
13.17.2 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.17.3 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Shandong Visee Medical Devices Co., Ltd. Main Business Overview
13.17.5 Shandong Visee Medical Devices Co., Ltd. Latest Developments
13.18 Conlife Medical Scientific (Shenzhen) Co., Ltd.
13.18.1 Conlife Medical Scientific (Shenzhen) Co., Ltd. Company Information
13.18.2 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.18.3 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Conlife Medical Scientific (Shenzhen) Co., Ltd. Main Business Overview
13.18.5 Conlife Medical Scientific (Shenzhen) Co., Ltd. Latest Developments
13.19 Zhuhai NeuroSafe Medical Co., Ltd.
13.19.1 Zhuhai NeuroSafe Medical Co., Ltd. Company Information
13.19.2 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.19.3 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Zhuhai NeuroSafe Medical Co., Ltd. Main Business Overview
13.19.5 Zhuhai NeuroSafe Medical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Embolization Coils Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Neurovascular Embolization Coils by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Neurovascular Embolization Coils by Country/Region, 2021, 2025 & 2032
2.2 Neurovascular Embolization Coils Segment by Type
2.2.1 Complex Coils
2.2.2 Helical Coils
2.2.3 Neurovascular Embolization Coils Sales by Type
2.2.3.1 Global Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
2.2.3.2 Global Neurovascular Embolization Coils Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Neurovascular Embolization Coils Sale Price by Type (2021-2026)
2.3 Neurovascular Embolization Coils Segment by Embolization Role
2.3.1 Framing Coils
2.3.2 Filling Coils
2.3.3 Finishing Coils
2.3.4 Universal Coils
2.3.5 Neurovascular Embolization Coils Sales by Embolization Role
2.3.5.1 Global Neurovascular Embolization Coils Sales Market Share by Embolization Role (2021-2026)
2.3.5.2 Global Neurovascular Embolization Coils Revenue and Market Share by Embolization Role (2021-2026)
2.3.5.3 Global Neurovascular Embolization Coils Sale Price by Embolization Role (2021-2026)
2.4 Neurovascular Embolization Coils Segment by Coil Softness
2.4.1 Standard Coils
2.4.2 Soft Coils
2.4.3 Extra Soft and Super Soft Coils
2.4.4 Neurovascular Embolization Coils Sales by Coil Softness
2.4.4.1 Global Neurovascular Embolization Coils Sales Market Share by Coil Softness (2021-2026)
2.4.4.2 Global Neurovascular Embolization Coils Revenue and Market Share by Coil Softness (2021-2026)
2.4.4.3 Global Neurovascular Embolization Coils Sale Price by Coil Softness (2021-2026)
2.5 Neurovascular Embolization Coils Segment by Detachment Mechanism
2.5.1 Mechanical Detachment Coils
2.5.2 Electrolytic Detachment Coils
2.5.3 Others
2.5.4 Neurovascular Embolization Coils Sales by Detachment Mechanism
2.5.4.1 Global Neurovascular Embolization Coils Sales Market Share by Detachment Mechanism (2021-2026)
2.5.4.2 Global Neurovascular Embolization Coils Revenue and Market Share by Detachment Mechanism (2021-2026)
2.5.4.3 Global Neurovascular Embolization Coils Sale Price by Detachment Mechanism (2021-2026)
2.6 Neurovascular Embolization Coils Segment by Application
2.6.1 Intracranial Aneurysm Embolization
2.6.2 Cerebral Arteriovenous Malformation Embolization
2.6.3 Other Neurovascular Abnormality Embolization
2.6.4 Neurovascular Embolization Coils Sales by Application
2.6.4.1 Global Neurovascular Embolization Coils Sale Market Share by Application (2021-2026)
2.6.4.2 Global Neurovascular Embolization Coils Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Neurovascular Embolization Coils Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Neurovascular Embolization Coils Breakdown Data by Company
3.1.1 Global Neurovascular Embolization Coils Annual Sales by Company (2021-2026)
3.1.2 Global Neurovascular Embolization Coils Sales Market Share by Company (2021-2026)
3.2 Global Neurovascular Embolization Coils Annual Revenue by Company (2021-2026)
3.2.1 Global Neurovascular Embolization Coils Revenue by Company (2021-2026)
3.2.2 Global Neurovascular Embolization Coils Revenue Market Share by Company (2021-2026)
3.3 Global Neurovascular Embolization Coils Sale Price by Company
3.4 Key Manufacturers Neurovascular Embolization Coils Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Embolization Coils Product Location Distribution
3.4.2 Players Neurovascular Embolization Coils Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR EMBOLIZATION COILS BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Embolization Coils Market Size by Geographic Region (2021-2026)
4.1.1 Global Neurovascular Embolization Coils Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Neurovascular Embolization Coils Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Neurovascular Embolization Coils Market Size by Country/Region (2021-2026)
4.2.1 Global Neurovascular Embolization Coils Annual Sales by Country/Region (2021-2026)
4.2.2 Global Neurovascular Embolization Coils Annual Revenue by Country/Region (2021-2026)
4.3 Americas Neurovascular Embolization Coils Sales Growth
4.4 APAC Neurovascular Embolization Coils Sales Growth
4.5 Europe Neurovascular Embolization Coils Sales Growth
4.6 Middle East & Africa Neurovascular Embolization Coils Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Embolization Coils Sales by Country
5.1.1 Americas Neurovascular Embolization Coils Sales by Country (2021-2026)
5.1.2 Americas Neurovascular Embolization Coils Revenue by Country (2021-2026)
5.2 Americas Neurovascular Embolization Coils Sales by Type (2021-2026)
5.3 Americas Neurovascular Embolization Coils Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Embolization Coils Sales by Region
6.1.1 APAC Neurovascular Embolization Coils Sales by Region (2021-2026)
6.1.2 APAC Neurovascular Embolization Coils Revenue by Region (2021-2026)
6.2 APAC Neurovascular Embolization Coils Sales by Type (2021-2026)
6.3 APAC Neurovascular Embolization Coils Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Embolization Coils by Country
7.1.1 Europe Neurovascular Embolization Coils Sales by Country (2021-2026)
7.1.2 Europe Neurovascular Embolization Coils Revenue by Country (2021-2026)
7.2 Europe Neurovascular Embolization Coils Sales by Type (2021-2026)
7.3 Europe Neurovascular Embolization Coils Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Embolization Coils by Country
8.1.1 Middle East & Africa Neurovascular Embolization Coils Sales by Country (2021-2026)
8.1.2 Middle East & Africa Neurovascular Embolization Coils Revenue by Country (2021-2026)
8.2 Middle East & Africa Neurovascular Embolization Coils Sales by Type (2021-2026)
8.3 Middle East & Africa Neurovascular Embolization Coils Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Embolization Coils
10.3 Manufacturing Process Analysis of Neurovascular Embolization Coils
10.4 Industry Chain Structure of Neurovascular Embolization Coils
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Embolization Coils Distributors
11.3 Neurovascular Embolization Coils Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR EMBOLIZATION COILS BY GEOGRAPHIC REGION
12.1 Global Neurovascular Embolization Coils Market Size Forecast by Region
12.1.1 Global Neurovascular Embolization Coils Forecast by Region (2027-2032)
12.1.2 Global Neurovascular Embolization Coils Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Neurovascular Embolization Coils Forecast by Type (2027-2032)
12.7 Global Neurovascular Embolization Coils Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.1.3 Stryker Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Medtronic plc
13.2.1 Medtronic plc Company Information
13.2.2 Medtronic plc Neurovascular Embolization Coils Product Portfolios and Specifications
13.2.3 Medtronic plc Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medtronic plc Main Business Overview
13.2.5 Medtronic plc Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Neurovascular Embolization Coils Product Portfolios and Specifications
13.3.3 Johnson & Johnson Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Terumo Corporation
13.4.1 Terumo Corporation Company Information
13.4.2 Terumo Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.4.3 Terumo Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Terumo Corporation Main Business Overview
13.4.5 Terumo Corporation Latest Developments
13.5 Penumbra, Inc.
13.5.1 Penumbra, Inc. Company Information
13.5.2 Penumbra, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
13.5.3 Penumbra, Inc. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Penumbra, Inc. Main Business Overview
13.5.5 Penumbra, Inc. Latest Developments
13.6 Balt Group
13.6.1 Balt Group Company Information
13.6.2 Balt Group Neurovascular Embolization Coils Product Portfolios and Specifications
13.6.3 Balt Group Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Balt Group Main Business Overview
13.6.5 Balt Group Latest Developments
13.7 Kaneka Corporation
13.7.1 Kaneka Corporation Company Information
13.7.2 Kaneka Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.7.3 Kaneka Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Kaneka Corporation Main Business Overview
13.7.5 Kaneka Corporation Latest Developments
13.8 Genesis MedTech Group
13.8.1 Genesis MedTech Group Company Information
13.8.2 Genesis MedTech Group Neurovascular Embolization Coils Product Portfolios and Specifications
13.8.3 Genesis MedTech Group Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Genesis MedTech Group Main Business Overview
13.8.5 Genesis MedTech Group Latest Developments
13.9 MicroPort NeuroScientific Corporation
13.9.1 MicroPort NeuroScientific Corporation Company Information
13.9.2 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
13.9.3 MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MicroPort NeuroScientific Corporation Main Business Overview
13.9.5 MicroPort NeuroScientific Corporation Latest Developments
13.10 Wallaby Medical Holding, Inc.
13.10.1 Wallaby Medical Holding, Inc. Company Information
13.10.2 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
13.10.3 Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wallaby Medical Holding, Inc. Main Business Overview
13.10.5 Wallaby Medical Holding, Inc. Latest Developments
13.11 Shanghai HeartCare Medical Technology Corporation Limited
13.11.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
13.11.2 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Product Portfolios and Specifications
13.11.3 Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shanghai HeartCare Medical Technology Corporation Limited Main Business Overview
13.11.5 Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
13.12 Peijia Medical Limited
13.12.1 Peijia Medical Limited Company Information
13.12.2 Peijia Medical Limited Neurovascular Embolization Coils Product Portfolios and Specifications
13.12.3 Peijia Medical Limited Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Peijia Medical Limited Main Business Overview
13.12.5 Peijia Medical Limited Latest Developments
13.13 Zylox-Tonbridge Medical Technology Co., Ltd.
13.13.1 Zylox-Tonbridge Medical Technology Co., Ltd. Company Information
13.13.2 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.13.3 Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Zylox-Tonbridge Medical Technology Co., Ltd. Main Business Overview
13.13.5 Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
13.14 Beijing Taijieweiye Technology Co., Ltd.
13.14.1 Beijing Taijieweiye Technology Co., Ltd. Company Information
13.14.2 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.14.3 Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Beijing Taijieweiye Technology Co., Ltd. Main Business Overview
13.14.5 Beijing Taijieweiye Technology Co., Ltd. Latest Developments
13.15 Shunmei Medical Co., LTD
13.15.1 Shunmei Medical Co., LTD Company Information
13.15.2 Shunmei Medical Co., LTD Neurovascular Embolization Coils Product Portfolios and Specifications
13.15.3 Shunmei Medical Co., LTD Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Shunmei Medical Co., LTD Main Business Overview
13.15.5 Shunmei Medical Co., LTD Latest Developments
13.16 Hunan Ruikangtong Technology Development Co., Ltd.
13.16.1 Hunan Ruikangtong Technology Development Co., Ltd. Company Information
13.16.2 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.16.3 Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Hunan Ruikangtong Technology Development Co., Ltd. Main Business Overview
13.16.5 Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
13.17 Shandong Visee Medical Devices Co., Ltd.
13.17.1 Shandong Visee Medical Devices Co., Ltd. Company Information
13.17.2 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.17.3 Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Shandong Visee Medical Devices Co., Ltd. Main Business Overview
13.17.5 Shandong Visee Medical Devices Co., Ltd. Latest Developments
13.18 Conlife Medical Scientific (Shenzhen) Co., Ltd.
13.18.1 Conlife Medical Scientific (Shenzhen) Co., Ltd. Company Information
13.18.2 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.18.3 Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Conlife Medical Scientific (Shenzhen) Co., Ltd. Main Business Overview
13.18.5 Conlife Medical Scientific (Shenzhen) Co., Ltd. Latest Developments
13.19 Zhuhai NeuroSafe Medical Co., Ltd.
13.19.1 Zhuhai NeuroSafe Medical Co., Ltd. Company Information
13.19.2 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
13.19.3 Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Zhuhai NeuroSafe Medical Co., Ltd. Main Business Overview
13.19.5 Zhuhai NeuroSafe Medical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurovascular Embolization Coils Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neurovascular Embolization Coils Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Complex Coils
Table 4. Major Players of Helical Coils
Table 5. Global Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 6. Global Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Table 7. Global Neurovascular Embolization Coils Revenue by Type (2021-2026) & ($ million)
Table 8. Global Neurovascular Embolization Coils Revenue Market Share by Type (2021-2026)
Table 9. Global Neurovascular Embolization Coils Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Framing Coils
Table 11. Major Players of Filling Coils
Table 12. Major Players of Finishing Coils
Table 13. Major Players of Universal Coils
Table 14. Global Neurovascular Embolization Coils Sales by Embolization Role (2021-2026) & (K Units)
Table 15. Global Neurovascular Embolization Coils Sales Market Share by Embolization Role (2021-2026)
Table 16. Global Neurovascular Embolization Coils Revenue by Embolization Role (2021-2026) & ($ million)
Table 17. Global Neurovascular Embolization Coils Revenue Market Share by Embolization Role (2021-2026)
Table 18. Global Neurovascular Embolization Coils Sale Price by Embolization Role (2021-2026) & (US$/Unit)
Table 19. Major Players of Standard Coils
Table 20. Major Players of Soft Coils
Table 21. Major Players of Extra Soft and Super Soft Coils
Table 22. Global Neurovascular Embolization Coils Sales by Coil Softness (2021-2026) & (K Units)
Table 23. Global Neurovascular Embolization Coils Sales Market Share by Coil Softness (2021-2026)
Table 24. Global Neurovascular Embolization Coils Revenue by Coil Softness (2021-2026) & ($ million)
Table 25. Global Neurovascular Embolization Coils Revenue Market Share by Coil Softness (2021-2026)
Table 26. Global Neurovascular Embolization Coils Sale Price by Coil Softness (2021-2026) & (US$/Unit)
Table 27. Major Players of Mechanical Detachment Coils
Table 28. Major Players of Electrolytic Detachment Coils
Table 29. Major Players of Others
Table 30. Global Neurovascular Embolization Coils Sales by Detachment Mechanism (2021-2026) & (K Units)
Table 31. Global Neurovascular Embolization Coils Sales Market Share by Detachment Mechanism (2021-2026)
Table 32. Global Neurovascular Embolization Coils Revenue by Detachment Mechanism (2021-2026) & ($ million)
Table 33. Global Neurovascular Embolization Coils Revenue Market Share by Detachment Mechanism (2021-2026)
Table 34. Global Neurovascular Embolization Coils Sale Price by Detachment Mechanism (2021-2026) & (US$/Unit)
Table 35. Global Neurovascular Embolization Coils Sale by Application (2021-2026) & (K Units)
Table 36. Global Neurovascular Embolization Coils Sale Market Share by Application (2021-2026)
Table 37. Global Neurovascular Embolization Coils Revenue by Application (2021-2026) & ($ million)
Table 38. Global Neurovascular Embolization Coils Revenue Market Share by Application (2021-2026)
Table 39. Global Neurovascular Embolization Coils Sale Price by Application (2021-2026) & (US$/Unit)
Table 40. Global Neurovascular Embolization Coils Sales by Company (2021-2026) & (K Units)
Table 41. Global Neurovascular Embolization Coils Sales Market Share by Company (2021-2026)
Table 42. Global Neurovascular Embolization Coils Revenue by Company (2021-2026) & ($ millions)
Table 43. Global Neurovascular Embolization Coils Revenue Market Share by Company (2021-2026)
Table 44. Global Neurovascular Embolization Coils Sale Price by Company (2021-2026) & (US$/Unit)
Table 45. Key Manufacturers Neurovascular Embolization Coils Producing Area Distribution and Sales Area
Table 46. Players Neurovascular Embolization Coils Products Offered
Table 47. Neurovascular Embolization Coils Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 48. New Products and Potential Entrants
Table 49. Market M&A Activity & Strategy
Table 50. Global Neurovascular Embolization Coils Sales by Geographic Region (2021-2026) & (K Units)
Table 51. Global Neurovascular Embolization Coils Sales Market Share Geographic Region (2021-2026)
Table 52. Global Neurovascular Embolization Coils Revenue by Geographic Region (2021-2026) & ($ millions)
Table 53. Global Neurovascular Embolization Coils Revenue Market Share by Geographic Region (2021-2026)
Table 54. Global Neurovascular Embolization Coils Sales by Country/Region (2021-2026) & (K Units)
Table 55. Global Neurovascular Embolization Coils Sales Market Share by Country/Region (2021-2026)
Table 56. Global Neurovascular Embolization Coils Revenue by Country/Region (2021-2026) & ($ millions)
Table 57. Global Neurovascular Embolization Coils Revenue Market Share by Country/Region (2021-2026)
Table 58. Americas Neurovascular Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 59. Americas Neurovascular Embolization Coils Sales Market Share by Country (2021-2026)
Table 60. Americas Neurovascular Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 61. Americas Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 62. Americas Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 63. APAC Neurovascular Embolization Coils Sales by Region (2021-2026) & (K Units)
Table 64. APAC Neurovascular Embolization Coils Sales Market Share by Region (2021-2026)
Table 65. APAC Neurovascular Embolization Coils Revenue by Region (2021-2026) & ($ millions)
Table 66. APAC Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 67. APAC Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 68. Europe Neurovascular Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 69. Europe Neurovascular Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 70. Europe Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 71. Europe Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Neurovascular Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 73. Middle East & Africa Neurovascular Embolization Coils Revenue Market Share by Country (2021-2026)
Table 74. Middle East & Africa Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 75. Middle East & Africa Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 76. Key Market Drivers & Growth Opportunities of Neurovascular Embolization Coils
Table 77. Key Market Challenges & Risks of Neurovascular Embolization Coils
Table 78. Key Industry Trends of Neurovascular Embolization Coils
Table 79. Neurovascular Embolization Coils Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Neurovascular Embolization Coils Distributors List
Table 82. Neurovascular Embolization Coils Customer List
Table 83. Global Neurovascular Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 84. Global Neurovascular Embolization Coils Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Americas Neurovascular Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Americas Neurovascular Embolization Coils Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. APAC Neurovascular Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 88. APAC Neurovascular Embolization Coils Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Europe Neurovascular Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 90. Europe Neurovascular Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Middle East & Africa Neurovascular Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 92. Middle East & Africa Neurovascular Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Global Neurovascular Embolization Coils Sales Forecast by Type (2027-2032) & (K Units)
Table 94. Global Neurovascular Embolization Coils Revenue Forecast by Type (2027-2032) & ($ millions)
Table 95. Global Neurovascular Embolization Coils Sales Forecast by Application (2027-2032) & (K Units)
Table 96. Global Neurovascular Embolization Coils Revenue Forecast by Application (2027-2032) & ($ millions)
Table 97. Stryker Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 98. Stryker Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 99. Stryker Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Stryker Corporation Main Business
Table 101. Stryker Corporation Latest Developments
Table 102. Medtronic plc Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 103. Medtronic plc Neurovascular Embolization Coils Product Portfolios and Specifications
Table 104. Medtronic plc Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Medtronic plc Main Business
Table 106. Medtronic plc Latest Developments
Table 107. Johnson & Johnson Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Neurovascular Embolization Coils Product Portfolios and Specifications
Table 109. Johnson & Johnson Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Terumo Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 113. Terumo Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 114. Terumo Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Terumo Corporation Main Business
Table 116. Terumo Corporation Latest Developments
Table 117. Penumbra, Inc. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 118. Penumbra, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 119. Penumbra, Inc. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Penumbra, Inc. Main Business
Table 121. Penumbra, Inc. Latest Developments
Table 122. Balt Group Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 123. Balt Group Neurovascular Embolization Coils Product Portfolios and Specifications
Table 124. Balt Group Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Balt Group Main Business
Table 126. Balt Group Latest Developments
Table 127. Kaneka Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 128. Kaneka Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 129. Kaneka Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Kaneka Corporation Main Business
Table 131. Kaneka Corporation Latest Developments
Table 132. Genesis MedTech Group Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 133. Genesis MedTech Group Neurovascular Embolization Coils Product Portfolios and Specifications
Table 134. Genesis MedTech Group Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Genesis MedTech Group Main Business
Table 136. Genesis MedTech Group Latest Developments
Table 137. MicroPort NeuroScientific Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 138. MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 139. MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. MicroPort NeuroScientific Corporation Main Business
Table 141. MicroPort NeuroScientific Corporation Latest Developments
Table 142. Wallaby Medical Holding, Inc. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 143. Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 144. Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Wallaby Medical Holding, Inc. Main Business
Table 146. Wallaby Medical Holding, Inc. Latest Developments
Table 147. Shanghai HeartCare Medical Technology Corporation Limited Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 148. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Product Portfolios and Specifications
Table 149. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Shanghai HeartCare Medical Technology Corporation Limited Main Business
Table 151. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
Table 152. Peijia Medical Limited Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 153. Peijia Medical Limited Neurovascular Embolization Coils Product Portfolios and Specifications
Table 154. Peijia Medical Limited Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Peijia Medical Limited Main Business
Table 156. Peijia Medical Limited Latest Developments
Table 157. Zylox-Tonbridge Medical Technology Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 158. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 159. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Zylox-Tonbridge Medical Technology Co., Ltd. Main Business
Table 161. Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
Table 162. Beijing Taijieweiye Technology Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 164. Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Beijing Taijieweiye Technology Co., Ltd. Main Business
Table 166. Beijing Taijieweiye Technology Co., Ltd. Latest Developments
Table 167. Shunmei Medical Co., LTD Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 168. Shunmei Medical Co., LTD Neurovascular Embolization Coils Product Portfolios and Specifications
Table 169. Shunmei Medical Co., LTD Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Shunmei Medical Co., LTD Main Business
Table 171. Shunmei Medical Co., LTD Latest Developments
Table 172. Hunan Ruikangtong Technology Development Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 173. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 174. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Hunan Ruikangtong Technology Development Co., Ltd. Main Business
Table 176. Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
Table 177. Shandong Visee Medical Devices Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 178. Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 179. Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Shandong Visee Medical Devices Co., Ltd. Main Business
Table 181. Shandong Visee Medical Devices Co., Ltd. Latest Developments
Table 182. Conlife Medical Scientific (Shenzhen) Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 183. Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 184. Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. Conlife Medical Scientific (Shenzhen) Co., Ltd. Main Business
Table 186. Conlife Medical Scientific (Shenzhen) Co., Ltd. Latest Developments
Table 187. Zhuhai NeuroSafe Medical Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 188. Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 189. Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Zhuhai NeuroSafe Medical Co., Ltd. Main Business
Table 191. Zhuhai NeuroSafe Medical Co., Ltd. Latest Developments
Table 1. Neurovascular Embolization Coils Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Neurovascular Embolization Coils Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Complex Coils
Table 4. Major Players of Helical Coils
Table 5. Global Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 6. Global Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Table 7. Global Neurovascular Embolization Coils Revenue by Type (2021-2026) & ($ million)
Table 8. Global Neurovascular Embolization Coils Revenue Market Share by Type (2021-2026)
Table 9. Global Neurovascular Embolization Coils Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Framing Coils
Table 11. Major Players of Filling Coils
Table 12. Major Players of Finishing Coils
Table 13. Major Players of Universal Coils
Table 14. Global Neurovascular Embolization Coils Sales by Embolization Role (2021-2026) & (K Units)
Table 15. Global Neurovascular Embolization Coils Sales Market Share by Embolization Role (2021-2026)
Table 16. Global Neurovascular Embolization Coils Revenue by Embolization Role (2021-2026) & ($ million)
Table 17. Global Neurovascular Embolization Coils Revenue Market Share by Embolization Role (2021-2026)
Table 18. Global Neurovascular Embolization Coils Sale Price by Embolization Role (2021-2026) & (US$/Unit)
Table 19. Major Players of Standard Coils
Table 20. Major Players of Soft Coils
Table 21. Major Players of Extra Soft and Super Soft Coils
Table 22. Global Neurovascular Embolization Coils Sales by Coil Softness (2021-2026) & (K Units)
Table 23. Global Neurovascular Embolization Coils Sales Market Share by Coil Softness (2021-2026)
Table 24. Global Neurovascular Embolization Coils Revenue by Coil Softness (2021-2026) & ($ million)
Table 25. Global Neurovascular Embolization Coils Revenue Market Share by Coil Softness (2021-2026)
Table 26. Global Neurovascular Embolization Coils Sale Price by Coil Softness (2021-2026) & (US$/Unit)
Table 27. Major Players of Mechanical Detachment Coils
Table 28. Major Players of Electrolytic Detachment Coils
Table 29. Major Players of Others
Table 30. Global Neurovascular Embolization Coils Sales by Detachment Mechanism (2021-2026) & (K Units)
Table 31. Global Neurovascular Embolization Coils Sales Market Share by Detachment Mechanism (2021-2026)
Table 32. Global Neurovascular Embolization Coils Revenue by Detachment Mechanism (2021-2026) & ($ million)
Table 33. Global Neurovascular Embolization Coils Revenue Market Share by Detachment Mechanism (2021-2026)
Table 34. Global Neurovascular Embolization Coils Sale Price by Detachment Mechanism (2021-2026) & (US$/Unit)
Table 35. Global Neurovascular Embolization Coils Sale by Application (2021-2026) & (K Units)
Table 36. Global Neurovascular Embolization Coils Sale Market Share by Application (2021-2026)
Table 37. Global Neurovascular Embolization Coils Revenue by Application (2021-2026) & ($ million)
Table 38. Global Neurovascular Embolization Coils Revenue Market Share by Application (2021-2026)
Table 39. Global Neurovascular Embolization Coils Sale Price by Application (2021-2026) & (US$/Unit)
Table 40. Global Neurovascular Embolization Coils Sales by Company (2021-2026) & (K Units)
Table 41. Global Neurovascular Embolization Coils Sales Market Share by Company (2021-2026)
Table 42. Global Neurovascular Embolization Coils Revenue by Company (2021-2026) & ($ millions)
Table 43. Global Neurovascular Embolization Coils Revenue Market Share by Company (2021-2026)
Table 44. Global Neurovascular Embolization Coils Sale Price by Company (2021-2026) & (US$/Unit)
Table 45. Key Manufacturers Neurovascular Embolization Coils Producing Area Distribution and Sales Area
Table 46. Players Neurovascular Embolization Coils Products Offered
Table 47. Neurovascular Embolization Coils Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 48. New Products and Potential Entrants
Table 49. Market M&A Activity & Strategy
Table 50. Global Neurovascular Embolization Coils Sales by Geographic Region (2021-2026) & (K Units)
Table 51. Global Neurovascular Embolization Coils Sales Market Share Geographic Region (2021-2026)
Table 52. Global Neurovascular Embolization Coils Revenue by Geographic Region (2021-2026) & ($ millions)
Table 53. Global Neurovascular Embolization Coils Revenue Market Share by Geographic Region (2021-2026)
Table 54. Global Neurovascular Embolization Coils Sales by Country/Region (2021-2026) & (K Units)
Table 55. Global Neurovascular Embolization Coils Sales Market Share by Country/Region (2021-2026)
Table 56. Global Neurovascular Embolization Coils Revenue by Country/Region (2021-2026) & ($ millions)
Table 57. Global Neurovascular Embolization Coils Revenue Market Share by Country/Region (2021-2026)
Table 58. Americas Neurovascular Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 59. Americas Neurovascular Embolization Coils Sales Market Share by Country (2021-2026)
Table 60. Americas Neurovascular Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 61. Americas Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 62. Americas Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 63. APAC Neurovascular Embolization Coils Sales by Region (2021-2026) & (K Units)
Table 64. APAC Neurovascular Embolization Coils Sales Market Share by Region (2021-2026)
Table 65. APAC Neurovascular Embolization Coils Revenue by Region (2021-2026) & ($ millions)
Table 66. APAC Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 67. APAC Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 68. Europe Neurovascular Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 69. Europe Neurovascular Embolization Coils Revenue by Country (2021-2026) & ($ millions)
Table 70. Europe Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 71. Europe Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 72. Middle East & Africa Neurovascular Embolization Coils Sales by Country (2021-2026) & (K Units)
Table 73. Middle East & Africa Neurovascular Embolization Coils Revenue Market Share by Country (2021-2026)
Table 74. Middle East & Africa Neurovascular Embolization Coils Sales by Type (2021-2026) & (K Units)
Table 75. Middle East & Africa Neurovascular Embolization Coils Sales by Application (2021-2026) & (K Units)
Table 76. Key Market Drivers & Growth Opportunities of Neurovascular Embolization Coils
Table 77. Key Market Challenges & Risks of Neurovascular Embolization Coils
Table 78. Key Industry Trends of Neurovascular Embolization Coils
Table 79. Neurovascular Embolization Coils Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Neurovascular Embolization Coils Distributors List
Table 82. Neurovascular Embolization Coils Customer List
Table 83. Global Neurovascular Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 84. Global Neurovascular Embolization Coils Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Americas Neurovascular Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 86. Americas Neurovascular Embolization Coils Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. APAC Neurovascular Embolization Coils Sales Forecast by Region (2027-2032) & (K Units)
Table 88. APAC Neurovascular Embolization Coils Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Europe Neurovascular Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 90. Europe Neurovascular Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Middle East & Africa Neurovascular Embolization Coils Sales Forecast by Country (2027-2032) & (K Units)
Table 92. Middle East & Africa Neurovascular Embolization Coils Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Global Neurovascular Embolization Coils Sales Forecast by Type (2027-2032) & (K Units)
Table 94. Global Neurovascular Embolization Coils Revenue Forecast by Type (2027-2032) & ($ millions)
Table 95. Global Neurovascular Embolization Coils Sales Forecast by Application (2027-2032) & (K Units)
Table 96. Global Neurovascular Embolization Coils Revenue Forecast by Application (2027-2032) & ($ millions)
Table 97. Stryker Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 98. Stryker Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 99. Stryker Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Stryker Corporation Main Business
Table 101. Stryker Corporation Latest Developments
Table 102. Medtronic plc Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 103. Medtronic plc Neurovascular Embolization Coils Product Portfolios and Specifications
Table 104. Medtronic plc Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Medtronic plc Main Business
Table 106. Medtronic plc Latest Developments
Table 107. Johnson & Johnson Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Neurovascular Embolization Coils Product Portfolios and Specifications
Table 109. Johnson & Johnson Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Terumo Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 113. Terumo Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 114. Terumo Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Terumo Corporation Main Business
Table 116. Terumo Corporation Latest Developments
Table 117. Penumbra, Inc. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 118. Penumbra, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 119. Penumbra, Inc. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Penumbra, Inc. Main Business
Table 121. Penumbra, Inc. Latest Developments
Table 122. Balt Group Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 123. Balt Group Neurovascular Embolization Coils Product Portfolios and Specifications
Table 124. Balt Group Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Balt Group Main Business
Table 126. Balt Group Latest Developments
Table 127. Kaneka Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 128. Kaneka Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 129. Kaneka Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Kaneka Corporation Main Business
Table 131. Kaneka Corporation Latest Developments
Table 132. Genesis MedTech Group Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 133. Genesis MedTech Group Neurovascular Embolization Coils Product Portfolios and Specifications
Table 134. Genesis MedTech Group Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Genesis MedTech Group Main Business
Table 136. Genesis MedTech Group Latest Developments
Table 137. MicroPort NeuroScientific Corporation Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 138. MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Product Portfolios and Specifications
Table 139. MicroPort NeuroScientific Corporation Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. MicroPort NeuroScientific Corporation Main Business
Table 141. MicroPort NeuroScientific Corporation Latest Developments
Table 142. Wallaby Medical Holding, Inc. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 143. Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 144. Wallaby Medical Holding, Inc. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Wallaby Medical Holding, Inc. Main Business
Table 146. Wallaby Medical Holding, Inc. Latest Developments
Table 147. Shanghai HeartCare Medical Technology Corporation Limited Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 148. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Product Portfolios and Specifications
Table 149. Shanghai HeartCare Medical Technology Corporation Limited Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Shanghai HeartCare Medical Technology Corporation Limited Main Business
Table 151. Shanghai HeartCare Medical Technology Corporation Limited Latest Developments
Table 152. Peijia Medical Limited Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 153. Peijia Medical Limited Neurovascular Embolization Coils Product Portfolios and Specifications
Table 154. Peijia Medical Limited Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Peijia Medical Limited Main Business
Table 156. Peijia Medical Limited Latest Developments
Table 157. Zylox-Tonbridge Medical Technology Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 158. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 159. Zylox-Tonbridge Medical Technology Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Zylox-Tonbridge Medical Technology Co., Ltd. Main Business
Table 161. Zylox-Tonbridge Medical Technology Co., Ltd. Latest Developments
Table 162. Beijing Taijieweiye Technology Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 163. Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 164. Beijing Taijieweiye Technology Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Beijing Taijieweiye Technology Co., Ltd. Main Business
Table 166. Beijing Taijieweiye Technology Co., Ltd. Latest Developments
Table 167. Shunmei Medical Co., LTD Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 168. Shunmei Medical Co., LTD Neurovascular Embolization Coils Product Portfolios and Specifications
Table 169. Shunmei Medical Co., LTD Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Shunmei Medical Co., LTD Main Business
Table 171. Shunmei Medical Co., LTD Latest Developments
Table 172. Hunan Ruikangtong Technology Development Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 173. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 174. Hunan Ruikangtong Technology Development Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Hunan Ruikangtong Technology Development Co., Ltd. Main Business
Table 176. Hunan Ruikangtong Technology Development Co., Ltd. Latest Developments
Table 177. Shandong Visee Medical Devices Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 178. Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 179. Shandong Visee Medical Devices Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Shandong Visee Medical Devices Co., Ltd. Main Business
Table 181. Shandong Visee Medical Devices Co., Ltd. Latest Developments
Table 182. Conlife Medical Scientific (Shenzhen) Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 183. Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 184. Conlife Medical Scientific (Shenzhen) Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. Conlife Medical Scientific (Shenzhen) Co., Ltd. Main Business
Table 186. Conlife Medical Scientific (Shenzhen) Co., Ltd. Latest Developments
Table 187. Zhuhai NeuroSafe Medical Co., Ltd. Basic Information, Neurovascular Embolization Coils Manufacturing Base, Sales Area and Its Competitors
Table 188. Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Product Portfolios and Specifications
Table 189. Zhuhai NeuroSafe Medical Co., Ltd. Neurovascular Embolization Coils Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 190. Zhuhai NeuroSafe Medical Co., Ltd. Main Business
Table 191. Zhuhai NeuroSafe Medical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Neurovascular Embolization Coils
Figure 2. Neurovascular Embolization Coils Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Embolization Coils Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Neurovascular Embolization Coils Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neurovascular Embolization Coils Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neurovascular Embolization Coils Sales Market Share by Country/Region (2025)
Figure 10. Neurovascular Embolization Coils Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Complex Coils
Figure 12. Product Picture of Helical Coils
Figure 13. Global Neurovascular Embolization Coils Sales Market Share by Type in 2026
Figure 14. Global Neurovascular Embolization Coils Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Framing Coils
Figure 16. Product Picture of Filling Coils
Figure 17. Product Picture of Finishing Coils
Figure 18. Product Picture of Universal Coils
Figure 19. Global Neurovascular Embolization Coils Sales Market Share by Embolization Role in 2026
Figure 20. Global Neurovascular Embolization Coils Revenue Market Share by Embolization Role (2021-2026)
Figure 21. Product Picture of Standard Coils
Figure 22. Product Picture of Soft Coils
Figure 23. Product Picture of Extra Soft and Super Soft Coils
Figure 24. Global Neurovascular Embolization Coils Sales Market Share by Coil Softness in 2026
Figure 25. Global Neurovascular Embolization Coils Revenue Market Share by Coil Softness (2021-2026)
Figure 26. Product Picture of Mechanical Detachment Coils
Figure 27. Product Picture of Electrolytic Detachment Coils
Figure 28. Product Picture of Others
Figure 29. Global Neurovascular Embolization Coils Sales Market Share by Detachment Mechanism in 2026
Figure 30. Global Neurovascular Embolization Coils Revenue Market Share by Detachment Mechanism (2021-2026)
Figure 31. Neurovascular Embolization Coils Consumed in Intracranial Aneurysm Embolization
Figure 32. Global Neurovascular Embolization Coils Market: Intracranial Aneurysm Embolization (2021-2026) & (K Units)
Figure 33. Neurovascular Embolization Coils Consumed in Cerebral Arteriovenous Malformation Embolization
Figure 34. Global Neurovascular Embolization Coils Market: Cerebral Arteriovenous Malformation Embolization (2021-2026) & (K Units)
Figure 35. Neurovascular Embolization Coils Consumed in Other Neurovascular Abnormality Embolization
Figure 36. Global Neurovascular Embolization Coils Market: Other Neurovascular Abnormality Embolization (2021-2026) & (K Units)
Figure 37. Global Neurovascular Embolization Coils Sale Market Share by Application (2025)
Figure 38. Global Neurovascular Embolization Coils Revenue Market Share by Application in 2025
Figure 39. Neurovascular Embolization Coils Sales by Company in 2025 (K Units)
Figure 40. Global Neurovascular Embolization Coils Sales Market Share by Company in 2025
Figure 41. Neurovascular Embolization Coils Revenue by Company in 2025 ($ millions)
Figure 42. Global Neurovascular Embolization Coils Revenue Market Share by Company in 2025
Figure 43. Global Neurovascular Embolization Coils Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Neurovascular Embolization Coils Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 46. Americas Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 47. APAC Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 48. APAC Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 49. Europe Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 50. Europe Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 52. Middle East & Africa Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 53. Americas Neurovascular Embolization Coils Sales Market Share by Country in 2025
Figure 54. Americas Neurovascular Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 55. Americas Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 56. Americas Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 57. United States Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Neurovascular Embolization Coils Sales Market Share by Region in 2025
Figure 62. APAC Neurovascular Embolization Coils Revenue Market Share by Region (2021-2026)
Figure 63. APAC Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 64. APAC Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 65. China Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 69. India Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Neurovascular Embolization Coils Sales Market Share by Country in 2025
Figure 73. Europe Neurovascular Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 74. Europe Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 75. Europe Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 76. Germany Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 77. France Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Neurovascular Embolization Coils Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 84. Egypt Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Neurovascular Embolization Coils in 2026
Figure 90. Manufacturing Process Analysis of Neurovascular Embolization Coils
Figure 91. Industry Chain Structure of Neurovascular Embolization Coils
Figure 92. Channels of Distribution
Figure 93. Global Neurovascular Embolization Coils Sales Market Forecast by Region (2027-2032)
Figure 94. Global Neurovascular Embolization Coils Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Neurovascular Embolization Coils Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Neurovascular Embolization Coils Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Neurovascular Embolization Coils Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Neurovascular Embolization Coils Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Neurovascular Embolization Coils
Figure 2. Neurovascular Embolization Coils Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Embolization Coils Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Neurovascular Embolization Coils Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Neurovascular Embolization Coils Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Neurovascular Embolization Coils Sales Market Share by Country/Region (2025)
Figure 10. Neurovascular Embolization Coils Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Complex Coils
Figure 12. Product Picture of Helical Coils
Figure 13. Global Neurovascular Embolization Coils Sales Market Share by Type in 2026
Figure 14. Global Neurovascular Embolization Coils Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Framing Coils
Figure 16. Product Picture of Filling Coils
Figure 17. Product Picture of Finishing Coils
Figure 18. Product Picture of Universal Coils
Figure 19. Global Neurovascular Embolization Coils Sales Market Share by Embolization Role in 2026
Figure 20. Global Neurovascular Embolization Coils Revenue Market Share by Embolization Role (2021-2026)
Figure 21. Product Picture of Standard Coils
Figure 22. Product Picture of Soft Coils
Figure 23. Product Picture of Extra Soft and Super Soft Coils
Figure 24. Global Neurovascular Embolization Coils Sales Market Share by Coil Softness in 2026
Figure 25. Global Neurovascular Embolization Coils Revenue Market Share by Coil Softness (2021-2026)
Figure 26. Product Picture of Mechanical Detachment Coils
Figure 27. Product Picture of Electrolytic Detachment Coils
Figure 28. Product Picture of Others
Figure 29. Global Neurovascular Embolization Coils Sales Market Share by Detachment Mechanism in 2026
Figure 30. Global Neurovascular Embolization Coils Revenue Market Share by Detachment Mechanism (2021-2026)
Figure 31. Neurovascular Embolization Coils Consumed in Intracranial Aneurysm Embolization
Figure 32. Global Neurovascular Embolization Coils Market: Intracranial Aneurysm Embolization (2021-2026) & (K Units)
Figure 33. Neurovascular Embolization Coils Consumed in Cerebral Arteriovenous Malformation Embolization
Figure 34. Global Neurovascular Embolization Coils Market: Cerebral Arteriovenous Malformation Embolization (2021-2026) & (K Units)
Figure 35. Neurovascular Embolization Coils Consumed in Other Neurovascular Abnormality Embolization
Figure 36. Global Neurovascular Embolization Coils Market: Other Neurovascular Abnormality Embolization (2021-2026) & (K Units)
Figure 37. Global Neurovascular Embolization Coils Sale Market Share by Application (2025)
Figure 38. Global Neurovascular Embolization Coils Revenue Market Share by Application in 2025
Figure 39. Neurovascular Embolization Coils Sales by Company in 2025 (K Units)
Figure 40. Global Neurovascular Embolization Coils Sales Market Share by Company in 2025
Figure 41. Neurovascular Embolization Coils Revenue by Company in 2025 ($ millions)
Figure 42. Global Neurovascular Embolization Coils Revenue Market Share by Company in 2025
Figure 43. Global Neurovascular Embolization Coils Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Neurovascular Embolization Coils Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 46. Americas Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 47. APAC Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 48. APAC Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 49. Europe Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 50. Europe Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Neurovascular Embolization Coils Sales 2021-2026 (K Units)
Figure 52. Middle East & Africa Neurovascular Embolization Coils Revenue 2021-2026 ($ millions)
Figure 53. Americas Neurovascular Embolization Coils Sales Market Share by Country in 2025
Figure 54. Americas Neurovascular Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 55. Americas Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 56. Americas Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 57. United States Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Neurovascular Embolization Coils Sales Market Share by Region in 2025
Figure 62. APAC Neurovascular Embolization Coils Revenue Market Share by Region (2021-2026)
Figure 63. APAC Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 64. APAC Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 65. China Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 69. India Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Neurovascular Embolization Coils Sales Market Share by Country in 2025
Figure 73. Europe Neurovascular Embolization Coils Revenue Market Share by Country (2021-2026)
Figure 74. Europe Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 75. Europe Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 76. Germany Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 77. France Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Neurovascular Embolization Coils Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Neurovascular Embolization Coils Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Neurovascular Embolization Coils Sales Market Share by Application (2021-2026)
Figure 84. Egypt Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Neurovascular Embolization Coils Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Neurovascular Embolization Coils in 2026
Figure 90. Manufacturing Process Analysis of Neurovascular Embolization Coils
Figure 91. Industry Chain Structure of Neurovascular Embolization Coils
Figure 92. Channels of Distribution
Figure 93. Global Neurovascular Embolization Coils Sales Market Forecast by Region (2027-2032)
Figure 94. Global Neurovascular Embolization Coils Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Neurovascular Embolization Coils Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Neurovascular Embolization Coils Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Neurovascular Embolization Coils Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Neurovascular Embolization Coils Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Herpes Labialis Drugs Market Growth 2023-2029
US$ 3,660.00
February 2023
102 pages
Global Companion Animal Parasiticides Market Growth 2025-2031
US$ 3,660.00
December 2025
87 pages
Global African Horse Sickness Vaccines Market Growth 2024-2030
US$ 3,660.00
March 2024
84 pages
Global IVF Devices Market Growth 2024-2030
US$ 3,660.00
November 2024
109 pages
Global BCAA Market Growth 2025-2031
US$ 3,660.00
January 2025
92 pages
